NKTI partners with Bot MD to launch an AI Viber platform for kidney patient monitoring and early intervention in the Philippines.
The National Kidney and Transplant Institute (NKTI) today announced its partnership with AI health technology start-up Bot MD to scale the monitoring and care of its kidney patients across the Philippines with an AI-powered Viber-based patient monitoring platform.
Bot MD Care makes it easy for kidney patients or their caregivers to report their symptoms and conditions through simple monitoring forms that are automatically sent to them through Viber, a widely used consumer messaging chat app in the Philippines.
The monitoring form is illustrated with images to make it easy for patients to select the symptoms they are experiencing.
Hemodialysis patients can also report their symptoms to the NKTI clinical team.Patient assurance with immediate feedbackPatients can also submit images of their clinical condition including their dialysis access sites so that their clinical care team can easily monitor them for signs of infection.
The platform’s AI will automatically triage patient submissions for doctors and nurses to call out patients who are at risk of infection or require medical attention. The bot is also trained to respond to frequently asked patient questions in English and Tagalog and allows doctors and nurses to send targeted care messages and reminders to patients.
All patient submissions can be easily viewed on the Bot MD Care Dashboard (Mobile & Web). Doctors and Nurses can view alerts, patient submissions and also manage patients who are non compliant. Bot MD Care will be made available to all peritoneal dialysis patients, hemodialysis patients as well as post-kidney transplant patients under NKTI’s care.
In the near future, NKTI plans to expand the platform to help monitor other patient conditions such as post surgical Urology patients as well as power other consumer messaging platforms such as Facebook Messenger.
“One of the biggest challenges for us is the number of dialysis patients that we have to monitor. Many of our patients live in remote areas and have to travel a long distance to get to our hospital. Bot MD Care allows us to remotely monitor these patients using A.I. to triage their submissions so we can detect early stage infections and intervene quickly through teleconsultations or calls. Best of all, patients do not need to download any additional apps which helps to make it more convenient for them to report their condition to us.”
- Dr Romina A. Danguilan
Deputy Executive Director, Medical Services, National Kidney and Transplant Institute (NKTI)